CA
ALHC icon

Clearstead Advisors’s Alignment Healthcare ALHC Stock Holding History

Clearstead Advisors’s Portfolio ALHC Stock Details ALHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$239 Buy
+10
New +$192 ﹤0.01% 3145
2026
Q1 		– Sell
-22
Closed -$435 – 2264
2025
Q4 		$435 Sell
22
-347
-94% -$6.23K ﹤0.01% 2321
2025
Q3 		$6.44K Buy
+369
New +$5.47K ﹤0.01% 2066
2024
Q3 		– Sell
-179
Closed -$1.4K – 2043
2024
Q2 		$1.4K Buy
+179
New +$1.17K ﹤0.01% 1864

Other funds holding ALHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DPL
Danica Pension Livsforsikrings Copenhagen V $6.26B AUM 29.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Clearstead Advisors's ALHC Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Alignment Healthcare (ALHC) in Q2 2026: 10 shares worth $239. The stake represents ﹤0.01% of the portfolio and ranks #3145 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in ALHC as recently as Q4 2025.

Clearstead Advisors first reported a position in ALHC in Q2 2024 and has held it in 4 quarters since. The position peaked at $6.44K in Q3 2025. 120 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • Clearstead Advisors held 10 shares of Alignment Healthcare worth $239 as of Q2 2026.
  • Alignment Healthcare was a new Clearstead Advisors position in Q2 2026.
  • Alignment Healthcare made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #3145 holding.
  • Clearstead Advisors first reported a position in Alignment Healthcare in Q2 2024 and has held it in 4 quarters since.
  • Clearstead Advisors's Alignment Healthcare position peaked at $6.44K in Q3 2025.
  • 120 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.